PHARMACOVIGILANCE AND ADVERSE DRUG REACTION REPORTING-A REVIEW

S. Surekha and Dr. E. Bhavya, M.Pharm., Ph. D.*

ABSTRACT

Pharmacovigilance is an activity related to the detection, assessment, understanding, management and prevention of adverse drug reaction (ADR) in an individual patient and launched to ensure the safety of the marketed drug products. In India, tuberculosis and HIV infection have a high prevalence rate and the pharmacotherapy drugs are related to multiple drug adverse effects. Both the National Tuberculosis Control Program and National AIDS Control Organization accepted to collaborate with the Pharmacovigilance Programme of India (PVPI) in order to monitor the treatment of tuberculosis and HIV infection. National Coordinator Center (NCC) started a mobile phone application for stakeholders to improve ADR reporting. Many countries do not allow the patients to do ADR reporting, so PVPI created the source for ADR reporting by patients. In this review article, we provide an overview of the PVPI and created the awareness about the ADR reporting to minimize the morbidity and mortality caused due to ADR, which in turn decreases the occurrence of ADR and brings effective therapeutic management to the patients.

Keywords: Pharmacovigilance; Adverse Drug Reaction; Pharmacovigilance Programme of India; Reporting; Drug Safety.